A QSAR study of matrix metalloproteinases type 2 (MMP-2) inhibitors with cinnamoyl pyrrolidine derivatives

Scientia Pharmaceutica

Volumn 80, Issue 2, 2012, Pages 265-281

  De Melo, Eduardo Borges ^a  

^a UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

Author keywords

Cancer; Gelatinases; Matrix metalloproteinases; MMP2; OPS; QSAR

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE INHIBITOR; PYRROLIDINE DERIVATIVE;

ALGORITHM; ARTICLE; HUMAN; MULTIVARIATE ANALYSIS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RANDOMIZATION; VALIDATION STUDY; VARIANCE;

EID: 84865144829     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1112-21     Document Type: Article

References (49)

1. Kontogiorgis CA, Papaioannou P, Hadjipavlou-Litina DJ. Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results. Curr Med Chem. 2005; 12: 339-355. http://www.ncbi.nlm.nih.gov/pubmed/15723623
2. Pirard B. Insight into the structural determinants for selective inhibition of matrix metalloproteinases. Drug Discov Today. 2007; 12: 640-646. http://dx.doi.org/10.1016/j.drudis.2007.06.003
3. Tu G, Xu W, Huang H, Li S. Progress in the development of matrix metalloproteinase inhibitors. Curr Med Chem. 2008; 15: 1388-1395. http://dx.doi.org/10.2174/092986708784567680
4. Griffin MO, Ceballos G, Villarreal FJ. Tetracycline compounds with non-antimicrobial organ protective properties: Possible mechanisms of action. Pharmacol Res. 2011; 63: 102-107. http://dx.doi.org/10.1016/j.phrs.2010.10.004
5. Patrick GL. An Introduction to Medicinal Chemistry 4th ed. Oxford: Oxford University Press, 2009: 752 pp.
6. Al-Quntar AA, Baum O, Reich R, Srebnika M. Recently synthesized class of vinylphosphonates as potent matrix metalloproteinase (MMP-2) inhibitors. Arch Pharm. 2004; 337: 76-80. http://dx.doi.org/10.1002/ardp.200300828
7. Li X, Li J. Recent advances in the development of MMPIs and APNIs based on the pyrrolidine plataforms. Mini Rev Med Chem. 2010; 10: 794-805. http://dx.doi.org/10.2174/138955710791608334
8. Zhang L, Zhang J, Fang H, Wanga Q, Xua W. Design, synthesis and preliminary evaluation of new cinnamoyl pyrrolidine derivatives as potent gelatinase inhibitors. Bioorg Med Chem. 2006; 14: 8286-8294. http://dx.doi.org/10.1016/j.bmc.2006.09.015
9. Ribeiro FAL, Ferreira MMC. QSPR models of boiling point, octanol-water partition coefficient and retention time index of polycyclic aromatic hydrocarbons. J Mol Struct Theochem. 2003; 663: 109-126. http://dx.doi.org/10.1016/j.theochem.2003.08.107
10. Molfetta FA, Bruni AT, Rosseli FP, Silva ABF. A partial least squares and principal component regression study of quinone compounds with trypanocidal activity. Struct Chem. 2007; 18: 49-57. http://dx.doi.org/10.1007/s11224-006-9120-3
11. QSAR Modeling, version 2.0. Theoretical and Applied Chemometrics Laboratory, State University of Campinas, Brazil. http://lqta.iqm.unicamp.br.
12. Teófilo RF, Martins JP, Ferreira MMC. Sorting variables by using informative vectors as a strategy for feature selection in multivariate regression. J Chemometrics. 2009; 23: 32-48. http://dx.doi.org/10.1002/cem.1192
13. Hernández N, Kiralj R, Ferreira MMC, Talavera I. Critical comparative analysis, validation and interpretation of SVM and PLS regression models in a QSAR study on HIV-1 protease inhibitors. Chemometr Intell Lab. 98; 65-77. http://dx.doi.org/10.1016/j.chemolab.2009.04.012
14. Melo EB. Multivariate SAR/QSAR of 3-aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase (FAS) inhibitors. Eur J Med Chem. 2010; 45: 5817-5826. http://dx.doi.org/10.1016/j.ejmech.2010.09.044
15. Melo EB. A new quantitative structure-property relationship model to predict bioconcentration factors of polychlorinated biphenyls (PCBs) in fishes using E-state index and topological descriptors. Ecotoxicol Environ Saf. 2012; 75: 213-222. http://dx.doi.org/10.1016/j.ecoenv.2011.08.026
16. van de Waterbeemd H, ed. PLS for multivariate linear modeling. In: Chemometric Methods in Molecular Design. Weinheim: Wiley-VCH, 1998: 195-218.
17. Gramatica P. Principles of QSAR models validation: internal and external. QSAR Comb Chem. 2007; 26: 694-701. http://dx.doi.org/10.1002/qsar.200610151
18. Kiralj R, Ferreira MMC. Basic validation procedures for regression models in QSAR and QSPR studies: theory and application. J Braz Chem Soc. 2009; 20: 770-787. http://dx.doi.org/10.1590/S0103-50532009000400021
19. Eriksson L, Jaworska J, Worth AP, Cronin MTD, McDowell RM, Gramatica P. Methods for reliability and uncertainty assessment and for applicability evaluations of classification and regression-based QSARs. Environ Health Perspect. 2003; 111: 1361-1375. http://dx.doi.org/10.1289/ehp.5758
20. Melagraki G, Afantitis A, Sarimveis H, Koutentis PA, Markopolus J, Igglessi-Markopoulou O. Optimization of biaryl piperidine and 4-amino-2-biarylurea MCH1 receptor antagonists using QSAR modeling, classification techniques and virtual screening. J Comput Aided Mol Des. 2007; 21: 251-267. http://dx.doi.org/10.1007/s10822-007-9112-4
21. van de Waterbeemd H, ed. Statistical validation of QSAR results. In: Chemometric Methods in Molecular Design. Weinheim: Wiley-VCH, 1998: 309-318.
22. Golbraikh A, Tropsha A. Beware of q2! J Mol Graph Model. 2002; 20: 269-276. http://dx.doi.org/10.1016/S1093-3263(01)00123-1
23. Aptula AO, Jeliazkova NG, Schultz TW, Cronin MTD. The better predictive model: high q2 for the training set or low root mean square error of prediction for the test set? QSAR Comb Chem. 2005; 24: 385-396. http://dx.doi.org/10.1002/qsar.200430909
24. Consonni V, Ballabio D, Todeschini R. 2010. Evaluation of model predictive ability by external validation techniques. J Chemometrics. 2010: 24, 194-201. http://dx.doi.org/10.1002/cem.1290
25. Golbraikh, A., Shen M, Xiao Z, Xiao Y, Lee K, Tropsha A. Rational selection of training and test set for the development of validated QSAR models. QSAR Comb Chem. 2003; 17: 241-253. http://dx.doi.org/10.1023/A:1025386326946
26. Todeschini R, Consonni V. Molecular Descriptors for Chemoinformatics. 2th ed. Volume 1: alphabetical listing. Weinheim: Wiley-VCH, 2009: 967 pp.
27. Organization for Economic Co-Operation and Development (OECD). Guidance document on the validation of (quantitative) structure-activity relationship [(Q)SAR] models. http://www.oecd.org/dataoecd/33/37/37849783.pdf
28. Cheng M, De B, Almstead NG, Pikul S, Dowty ME, Dietsch CR, Dunaway CM, Gu F, Hsieh LC, Janusz MJ, Taiwo YO, Natchus MG, Hudlicky T, Mandel M. Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold. J Med Chem. 1999; 42: 5426-5436. http://dx.doi.org/10.1021/jm9904699
29. Discovery Studio Visualizer, version 2.5.5.9350. Accelrys Software Inc, www.accelrys.com
30. Liu Y, Ke Z, Cui J, Chen W, Ma L, Wang B. Synthesis, inhibitory activities, and QSAR study of xanthone derivatives as α-glucosidase inhibitors. Bioorg Med Chem. 2008; 16: 7185-7192. http://dx.doi.org/10.1016/j.bmc.2008.06.043
31. Dragon, version web 3.0. Talete srl, www.talete.mi.it
32. Marvin, version 4.1.8. ChemAxon Inc. www.chemaxon.com/marvin
33. Miller KJ, Savchik, JA. A new empirical method to calculate average molecular polarizabilities. J Am Chem Soc. 1979; 101: 7206-7213. http://dx.doi.org/10.1021/ja00518a014
34. Devillers J, Balaban AT; eds. Topological Indices and Related Descriptors in QSAR and QSPR. London: Gordon and Breach, 1999: 491-562.
35. Hyperchem, version 7.1. Hyper Co. www.hyper.com
36. Irwin JJ, Shoichet BK. ZINC - a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005; 45: 177-182. http://dx.doi.org/10.1021/ci049714+
37. Gaussian, version 09. Gaussian Inc, www.gaussian.com
38. Weininger D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Comput Sci. 1988; 28: 31-48. http://dx.doi.org/10.1021/ci00057a005
39. Parameter Client. Virtual Computational Chemistry Laboratory. www.vcclab.org/lab/pclient
40. Gauss View Gauss View, version 05. Gaussian Inc, www.gaussian.com
41. Young DC. Computational chemistry: a practical guide for applying techniques to real-world problems. New York: Wiley-Interscience, 2001: 369 pp.
42. Wold S, Sjöström M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemometr Intell Lab. 2001; 58: 109-130. http://dx.doi.org/10.1016/S0169-7439(01)00155-1
43. Roy PP, Roy K. On Some Aspects of Variable Selection for Partial Least Squares Regression Models. QSAR Comb Sci. 2008; 27: 302-313. http://dx.doi.org/10.1002/qsar.200710043
44. Ferreira MMC, Montanari CA, Gaudio AC. Variable selection in QSAR. Quím Nova. 2002; 25: 439-448. http://dx.doi.org/10.1590/S0100-40422002000300017
45. González MP, Terán C, Saíz-Urra L, Teijeira M. Variable selection methods in QSAR: an overview. Curr Top Med Chem. 2008; 8:1606-1627. http://dx.doi.org/10.2174/156802608786786552
46. Gaudio AC, Zandonade E. Proposition, validation and analysis of QSAR models. Quím Nova 2001; 24: 658-671. http://dx.doi.org/10.1590/S0100-40422001000500013
47. Beebe KR, Pell RJ, Seasholtz MB. Chemometrics: a practical guide. Wiley: New York, 1998: 360 pp.
48. Pirouette, version 4. Infometrix Inc. www.infometrix.com
49. Roy PP, Leonard JT, Roy K. Exploring the impact of size of training sets for the development of predictive QSAR models. Chemometr Intell Lab. 2008; 90: 31-42. http://dx.doi.org/10.1016/j.chemolab.2007.07.004